First choice for refractory OAB: botulinum toxin A or sacral neuromodulation?

Findlay MacAskill and Arun Sahai
Peer Reviewer
Sohier Elneil
Date of Publication
November 2023

Subscribe here to access e-learning and easily manage your CPD records

Sign up now

Or contact us for group rates

Already a subscriber? Log in here